81 POSTER Preclinical pharmacodynamic markers of MGCD265, a potent orally active c-Met/VEGFR multitargeted kinase inhibitor in Phase I clinical trials
Beaulieu, N, Dupont, I, Beaulieu, C, Nguyen, H, Ste-Croix, H, Claridge, S, Isakovic, L, Vaisburg, A, Besterman, J.M, Maroun, C
Published in European journal of cancer supplements (2008)
Published in European journal of cancer supplements (2008)
Get full text
Journal Article
Potent preclinical antitumor activity of MGCD265, an oral Met/VEGFR kinase inhibitor in phase II clinical development, in combination with taxanes or erlotinib
Besterman, J. M., Fournel, M., Dupont, I., Bonfils, C., Dubay, M., Ste-Croix, H., Maroun, C. R.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Effects of Cyclosporin A, Rapamycin, and FK520 on Peripheral T-Cell Deletion and Anergy
Prud'homme, Gérald J., Vanier, Laurent E., Bocarro, Danita C., Ste-Croix, Hékéne
Published in Cellular immunology (01.08.1995)
Published in Cellular immunology (01.08.1995)
Get full text
Journal Article
T-cell maturation and clonal deletion in cyclosporine-induced autoimmunity
Prud'homme, Gerald J., Sanders, Richard, Parfrey, Nollaig A., Ste-Croix, Helene
Published in Journal of autoimmunity (01.04.1991)
Published in Journal of autoimmunity (01.04.1991)
Get full text
Journal Article